Clinical Trial Update: Incretin Regulation of Insulin Secretion in Monogenic Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating incretin regulation of insulin secretion in individuals with monogenic diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monogenic Diabetes

Snippet

Sponsor: University of Chicago | Conditions: Monogenic Diabetes | Phase 1 | Status: COMPLETED